Article
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Pathologie-biologie - 1 Sept 2001
Tankovic J, Lamarque D, Lascols C, Soussy C J, Delchier J C
Abstract excerpt
Clarithromycin resistance of Helicobacter pylori is relatively frequent in France and is assumed to be the main cause of failure of the proton pump inhibitor-amoxicillin-clarithromycin (PPI-AC) therapy, which is the first-line regimen in our country. We determined the respective effects of clarithromycin primary and secondary resistances on efficacy of the PPI-AC regimen and examined whether failures were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
